Business Description
Protagenic Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US74365N2027
Description
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.2 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.53 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -7.9 | |||||
| 3-Year EPS without NRI Growth Rate | 2.8 | |||||
| 3-Year FCF Growth Rate | -19.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | -24.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.03 | |||||
| Quick Ratio | 2.03 | |||||
| Cash Ratio | 1.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.6 | |||||
| Shareholder Yield % | -1.57 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -198.14 | |||||
| ROA % | -154.53 | |||||
| ROIC % | -2514.13 | |||||
| 3-Year ROIIC % | -4937.5 | |||||
| ROC (Joel Greenblatt) % | -8152.56 | |||||
| ROCE % | -196.75 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.54 | |||||
| Price-to-Tangible-Book | 3.54 | |||||
| EV-to-EBIT | 0.13 | |||||
| EV-to-EBITDA | 0.13 | |||||
| EV-to-FCF | 0.16 | |||||
| Price-to-Net-Current-Asset-Value | 3.94 | |||||
| Price-to-Net-Cash | 10.5 | |||||
| Earnings Yield (Greenblatt) % | 769.23 | |||||
| FCF Yield % | -123.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Protagenic Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.3 | ||
| Beta | 0 | ||
| Volatility % | 21.79 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0 | ||
| 20-Day SMA (€) | 1.466 | ||
| 12-1 Month Momentum % | -24.43 | ||
| 52-Week Range (€) | 1.18 - 2 | ||
| Shares Outstanding (Mil) | 4.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Protagenic Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Protagenic Therapeutics Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Protagenic Therapeutics Inc Frequently Asked Questions
What is Protagenic Therapeutics Inc(FRA:MBP)'s stock price today?
The current price of FRA:MBP is €1.47. The 52 week high of FRA:MBP is €2.00 and 52 week low is €1.18.
When is next earnings date of Protagenic Therapeutics Inc(FRA:MBP)?
The next earnings date of Protagenic Therapeutics Inc(FRA:MBP) is 2024-11-14 Est..
Does Protagenic Therapeutics Inc(FRA:MBP) pay dividends? If so, how much?
Protagenic Therapeutics Inc(FRA:MBP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers